Aim: Following toll-like receptor (TLR) engagement, lipopolysaccharide (LPS) can stimulate the expression of pro-inflammatory cytokines thus activating the innate immune response. The production of inflammatory cytokines results, in part, from the activation of kinase-induced signalling cascades and transcriptional factors. Of the four distinct classes of mitogen-activated protein kinases (MAPK) described in mammals, p38, c-Jun N-terminal activated kinases (JNK1-3) and extracellular activated kinases (ERK1,2) are the best studied. Previous data have established that p38 MAPK signalling is required for inflammation and bone loss in periodontal disease pre-clinical animal models. Materials & Methods: In this study, we obtained healthy and diseased periodontal tissues along with clinical parameters and microbiological parameters. Excised fixed tissues were immunostained with total and phospho-specific antibodies against p38, JNK and ERK kinases. Results: Intensity scoring from immunostained tissues was correlated with clinical periodontal parameters. Rank correlations with clinical indices were statistically significantly positive (p-value < 0.05) for total p38 (correlations ranging 0.49-0.68), phospho-p38 (range 0.44-0.56), and total ERK (range 0.52-0.59) levels, and correlations with JNK levels also supported association (range 0.42-0.59). Phospho-JNK and phospho-ERK showed no significant positive correlation with clinical parameters of disease. Conclusion: These data strongly implicate p38 MAPK as a major MAPK involved in human periodontal inflammation and severity.
In the periodontal microenvironment, bacterial constituents including gramnegative derived lipopolysaccharide (LPS) can initiate inflammatory bone loss as appreciated in periodontal diseases. LPS can stimulate the expression of IL-1b, TNF-a, IL-6 and receptor activator of NFjB Ligand (RANKL) by activating the innate immune response as well as nonimmune cells such as gingival fibroblasts (Nakashima et al. 2000 , Jiang et al. 2002 , Kikuchi et al. 2003 . The production of inflammatory cytokines results from the activation of kinase-induced signalling cascades and transcriptional factors. Within periodontal diseased tissues monocytes, macrophages and fibroblasts, all produce cytokines such as TNF-a, IL-1b, PGE 2 and IL-6 (Lee et al. 1995 , Reddi et al. 1996 and have all been found to be significantly elevated in diseased periodontal sites compared to healthy or inactive sites (Stashenko et al. 1991 , Geivelis et al. 1993 , Gamonal et al. 2000 , Ejeil et al. 2003 , Gorska et al. 2003 . These cytokines orchestrate the cascade of destructive events that occur in the periodontal tissues, and trigger the production of an array of inflammatory enzymes and mediators including MMPs and prostaglandins. Moreover, pro-inflammatory cytokines directly or indirectly recruit and activate osteoclasts through RANKL-dependent and independent pathways, resulting in irreversible periodontal bone destruction (Assuma et al. 1998 , Graves 1999 ). Therefore, knowledge regarding the molecular pathways that govern expression of many inflammatory mediators may have therapeutic significance in the management of inflammatory diseases including chronic periodontitis.
Bacterial LPS initiates the innate immune signalling cascade through interaction with cell surface protein expressed CD14 as well as toll-like receptors (TLRs), mainly TLR-2 and TLR-4 (Kirschning et al. 1998 , Yang et al. 2000 , Kirschning & Bauer 2001 . Expression of both TLR-2 and TLR-4 is increased in periodontal disease tissues, suggesting that these receptors have an increased capacity to signal and influence downstream cytokine expression (Mori et al. 2003 , Beklen et al. 2008 . TLR-4 signalling activates MyD88-dependent pathways to subsequent activation of interleukin-1R-associated kinase (IRAK), tumour necrosis factor receptorassociated factor-6 (TRAF6) and ultimately nuclear factor kappa B (NF-jB) required for cytokine induction. Also, TRAF6-dependent pathways are required for recruitment of different adaptor proteins and activation of various mitogen activating protein kinases (MAPK) and activation of nuclear factor kappa B (NF-jB). The transcription factors NF-jB and activator protein-1 (AP-1) control expression of some of the most common inflammatory mediators present in periodontal inflammation, including IL-1, IL-6, TNF-a and MMPs [reviewed in (Kirkwood & Rossa 2009)] .
Although both MAPK pathways and NF-jB signalling pathways are well established in regulation of inflammatory cytokines and MMP genes in periodontal diseases, considerable less information is known about MAPK than NF-jB signalling in human disease. MAPKs phosphorylate a number of intracellular targets, including transcription factors (e.g. AP-1 and CHOP) and RNA-binding proteins (e.g. tristetraprolin and HuR), which tightly regulate expression of inflammatory genes including at transcriptional and posttranscriptional levels. Target genes downstream of MAPK  signalling include many common  inflammatory mediators such as  IL-1, IL-6, TNF-a, COX-2 and  MMPs [recently reviewed in (Palanisamy et al. 2012) ].
Understanding the cell signalling processes involved in periodontal disease progression and destruction is key in the development of new therapeutic approaches to prevent or attenuate periodontal destruction. Pre-clinical periodontal disease models indicate that there is a strong positive correlation between activation of MAPKs, inflammation and bone loss (Kirkwood et al. 2007a , Rogers et al. 2007 , Kirkwood & Rossa 2009 , Li et al. 2011 . However, no data regarding the significance of MAPK activation in periodontal disease in humans have been evaluated. In the study, clinical periodontal parameters were correlated with the level of activation of MAPKs in subjects with chronic periodontal disease compared to healthy controls. Data obtained strongly indicate that total p38 and ERK have a significant positive correlation with periodontal disease severity while only phosphorylated p38 only correlates with clinical parameters of periodontal disease progression.
Materials and Methods
This study was approved by the Institutional Review Board for the Health Sciences at the University of Michigan, Ann Arbor, MI, USA. A total of twenty-one tissue samples from human subjects were included in the study (13 females and 8 males). The subjects were divided into two groups: healthy (10 subjects) and diseased (11 subjects). Informed consent was obtained with all patients prior to initiating study.
Prior to surgery, clinical parameters were measured at the same sites where tissues were harvested including: Plaque index (PI) on a scale of 0-3 (0-no plaque, 1-w/probe, 2-visible, 3-abundant) (Loe 1967) , Gingival Index (GI) on a scale of 0-3 (0-no inflammation, 1-mild, 2-moderate w/BOP, 3-severe, spontaneous) bleeding on probing (BOP), pocket depth (PD), BOP, gingival recession (REC) and clinical attachment level (CAL). Based on these parameters the inclusion criteria for the diseased group consisted of: at least 1 site with PD >4 mm, GI 1-3 and PI 1-3. For the healthy controls acceptable parameters were PD ≤4 mm, GI ≤1 and PI ≤2. The exclusion criteria for both groups included: smokers, unstable systemic diseases or chronic disorders (diabetes, rheumatoid arthritis), patients using steroids, antibiotics, NSAIDS and/or other host modulators. The procured samples were from tissues that would have been otherwise discarded after periodontal surgery and or extraction sites. When clinically indicated, procured tissues included connective tissue near the sulcular epithelium.
Microbial assessments: BANA test
The benzoyl-DL-arginine-naphthylamide test was used to determine the presence of "red-complex" periodontal pathogens (Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia) (Loesche et al. 1990 ) due to the unique ability of these pathogens to hydrolyse a synthetic trypsin substrate, BANA. Plaque was collected for BANA analysis from the surgical site prior to surgery. A curette was used for plaque collection from the site. After incubation for 5 min. at 35°C with Evan's black dye solution, naphthylamine was released as a result of the presence of any one of the "redcomplex" pathogens and formed a permanent blue-black colour. The test was read as positive or negative based on the relative intensity of the blue colour.
Tissue processing and immunohistochemistry
Immediately following procurement, the tissue samples were stored in vials containing 4% vol formaldehyde and phosphatase inhibitor cocktail (Phos-STOP, Roche Diagnostic, Germany). After 24-36 h they were transferred into 70% ethanol, embedded in paraffin and then sections were prepared. An attempt was made to cut the sections in such a manner so that every sample would have both the epithelium and underlying connective tissue whenever possible. Immunohistochemical staining for p38, phospho-p38, ERK, phospho-ERK, JNK and phospho-JNK was performed. Deparaffinized ethanol-dehydrated tissue sections were placed in a pressure chamber (Biocare Medical, Concord, CA, USA) for 15 min. in an antigen retrieval buffer (DAKO, Glostrup, Denmark) and allowed to cool to room temperature. Primary antibodies for p38, phospho-p38, ERK, phospho-ERK, JNK and phospho-JNK (Cell Signaling, Beverly, MA, USA; R&D Systems, Minneapolis, MN, USA and Abcam, Cambridge, MA, USA) were used to evaluate the extent of expression, detected using Vectastain Elite ABC reagent and Nova Red (Vector Laboratories, Burlingame, CA, USA) per manufacturer's instructions. Control sections were incubated as well with pre-immune serum or control IgG. An independent oral pathologist (NJD), blinded to the periodontal status of the subjects, completed the immunohistochemical staining scoring analysis of the inflammatory infiltrate in the connective tissue as previously described (Kirkwood et al. 2007b , Mitra et al. 2008 ). Due to high background staining, the epithelium was not scored. The examiner first went through all the slides for a particular stain and selected slides that represented each of the four levels of intensity. All slides were scored using reference slides as the standard. All slides were assigned a score of 0, 1, 2 or 3, where "0 = none", "1 = low", "2 = medium/ moderate" and "3 = high/severe" positive stain.
Inflammation intensity scoring
Serial sections from periodontal tissue samples were sectioned for standard haematoxylin and eosin (H&E) staining to correlate with immunohistochemical (IHC) staining. Specimens were assessed and read for the degree of inflammatory infiltrate by a blinded oral pathologist (NJD). Infiltrate intensity was scored as follows: none (less than mild), mild, moderate or severe.
Statistical analysis
All statistical analyses were performed using R version 2.12.1 (available at: http://cran.r-project.org/bin/ windows/base/old/2.12.1/). The raw immunohistochemical staining scores and periodontal outcomes of GI and plaque index (PI) are presented in table format. PD measurements associated with the tooth from which the tissue sample was taken were summarized using the periodontal inflammatory burden index, PIBI, defined as the number of PD measurements of 4 or 5 mm plus twice the number of PD measurements ≥6 mm (Lindy et al. 2008 , Leppilahti et al. 2011 ). We defined a summary clinical attachment level index, CALI, in an analogous fashion as the number of CAL measurements of 4 or 5 mm plus twice the number of CAL measurements ≥6 mm. The clinical summaries PIBI and CALI of the disease status of the area where tissue was taken range from 0 to 12, with higher values indicating more severe disease. Associations between the ordinal immunohistochemical staining outcomes for p38, phospho-p38, ERK, phospho-ERK, JNK and phospho-JNK and clinical periodontal outcomes were quantified using the Spearman rank correlation (computed using the function rcorr from the R package Hmisc (R package version 3.8-3, available at: http://cran.r-project.org/web/packages/ Hmisc/index.html). Confidence intervals for the correlations were obtained by back transforming normality-based confidence intervals for the Fisher transformation (Fisher 1915) of the estimated correlation. Because Fisher's transformation is non-linear, this back transformation of the symmetrical normality-based confidence interval results in an asymmetric confidence interval for the raw (untransformed) correlation.
Results

Subsets of MAPK expression correlates with inflammation and microbiological assessments
Twenty-one samples of periodontal tissues were collected from healthy subjects and chronic periodontitis patients. In the healthy group, nine samples of ten (90%) were graded as "none -no inflammatory infiltrate observed" with scattered focally present lymphocytes and occasionally plasma cells. One sample was graded as mild and in that case focally present lymphocytes, plasma cells and macrophages were observed. The diseased group consisted of no samples in the "none" category, four (36%) in the "mild", six (55%) in the "moderate" and one (9%) in the "severe". The diseased group exhibited significantly more inflammatory infiltrate, and lymphocytes, plasma cells and macrophages were present in almost all the samples. Occasionally, bacterial colonies were observed and interpreted as dental calculus as well as extravasated erythrocytes. IHC staining was performed on tissues following extensive optimization for each of the following antibodies: total p38, JNK and ERK along with phosphorylated (active) p38, JNK and ERK. Representative examples of total and phospho-p38 (Fig. 1) , total and phospho-JNK (Fig. 2) and total and phospho-ERK (Fig. 3) are presented.
The intensity of the IHC scoring and the intensity of the inflammatory infiltrate are both positively correlated with the clinical parameters (Tables 1, 2) . BANA scores showed a striking correlation with clinical disease parameters and IHC scoring (p-values ≤ 0.02 for p38, phosphop38, ERK and JNK; BANA scores were not significantly correlated with phospho-ERK and phospho-JNK). Figure 4 depicts the estimated correlations between the clinical parameters and IHC scoring together with 95% confidence intervals computed as described in the Methods section. The confidence intervals reinforce the pattern of association between the clinical parameters and MAPK expression. Specifically, the clinical parameters are consistently, significantly, and positively associated with the IHC scoring for p38, phospho-p38, ERK and JNK (with the sole exception that the confidence interval for the association between JNK and the summary index PIBI just covers zero; p-value = 0.06 from Table 2), and lack statistically significant correlation with phospho-ERK and phospho-JNK. Thus, MAPK expression, inflammatory infiltrate and BANA exhibit similar patterns of association with the clinical parameters.
Discussion
Pro-inflammatory cytokines have long been identified as major pathogenic mediators involved in the pathobiology of both rheumatoid arthritis periodontitis, inducing and propagating a chronic inflammatory process leading towards tissue and bone destruction (Kirkwood et al. 2007b) . In humans, MAPK activation has been evaluated in tissues from rheumatoid arthritis patients which has been well characterized as a chronic inflammatory disease where inflammatory, immunological and physical stimuli ultimately leading to tissue destruction (Zvaifler 1995a, Zvaifler 1995b , Firestein 1999 . MAPK signalling is vital for synthesis and amplification of proinflammatory mediators and MMPs by synovial cells, chemoattraction of mononuclear cells, and angiogenesis of endothelial cells, as well as in synovial cell apoptosis (Schett et al. 2000) , and p38a and p38b seemed to be predominantly activated in the inflamed tissue (Korb et al. 2006) . Given the similarities in cytokine networks between RA and periodontitis, we sought to understand if some of the major MAPK signalling pathways are operative during periodontal disease progression. This study evaluated and compared the expression and activation of p38, ERK and JNK MAPKs in gingival tissues from normal healthy subjects and subjects with chronic periodontitis. Activation of total p38, ERK and JNK in diseased tissues was evident but an even more significant finding was the observation of more intense immunoreactivity for phosphorylated p38 in diseased tissues compared to controls (Tables 1, 2 and Fig. 4 ) suggesting increased phosphorylation of p38 in human chronic periodontitis. These findings are in agreement with results from studies that demonstrated activation of p38, ERK and JNK in samples from patients with rheumatoid arthritis, and that p38, specifically isoforms a and b dominate in chronic inflammation (Schett et al. 2000 , Korb et al. 2006 . Although initial aetiology is different between periodontitis and rheumatoid arthritis, the signalling pathways used in response to bacterial challenge or proinflammatory cytokines are comparable. In fact, many of the same cytokines (including TNF-a, IL-1b and IL-6) are associated with progression in both diseases. Data from periodontal disease pre-clinical models using a p38a specific inhibitor suggest that at least p38a may be a major p38 isoform involved in inflammatory signalling in chronic periodontitis (Kirkwood et al. 2007b) .
Although this study is the first to address MAPK activation in human periodontitis, previous studies addressed NF-jB (p50/p65) and inhibitor of kappa B (IjB) expression in chronic periodontitis patients where activation of NF-jB (p50/p65) was more significantly expressed in diseased periodontal tissues (Ambili et al. 2005) . NF-jB and MAPK activation have also been shown to be instrumental in progression of inflammatory diseases including rheumatoid arthritis, cardiovascular disease (Cook et al. 1999 , Schett et al. 2000 ), Alzheimer's disease (Culbert et al. 2006 ) and cancer progression (Hanahan & Weinberg 2000) .
Clinical data and histological grading of periodontal lesions presented agrees with the historical literature in clinical periodontics (Page & Schroeder 1976) providing assurance that correlative data presented here relative to MAPK expression and activation is compelling. Intensity scoring from immunostained tissues presented in Tables 1, 2 along with graphical representation of these data in Fig. 4 was correlated with clinical periodontal parameters. Rank correlations with clinical indices were significantly positive for total p38, phospho-p38 and total ERK expression levels, along with total JNK levels. Phospho-JNK and phospho-ERK showed no significant positive correlation with clinical parameters of disease or BANA positivity. Since there was an increase in the inflammatory infiltrate in the diseased versus healthy sites, there was an increase in the number of nuclei within these sites. Thus, the total amount of p38, JNK and ERK expression maybe positively correlated with clinical indices since there were more cells within the periodontal lesions. The lack of correlative data with p-JNK and p-ERK suggests that although there is more total JNK and ERK, these MAPKs are not significantly active during periodontal disease progression in humans. One of the potential shortcomings of these data resides in the inability to express the phosphorylated to non-phosphorylated MAPKs ratios due to lack of sufficient amount of quality serial samples. However, it should be noted again, that the connective tissue was only scored and reported here since there was high background immunostaining with the epithelium.
It is important to note that diseased samples evaluated for inflammation, BANA and MAPK expression in this study all had initial periodontal therapy including scaling and root planing prior to tissue procurement. Thus, the levels of inflammation observed are most likely lower then what would be expected in an untreated periodontal lesion, suggesting that the significance of the data presented here is highly significant. However, although BANA data correlated with periodontal disease status, these studies cannot conclude that all periodontal pathogens affect MAPK signalling pathways to the same extent or manner.
With emerging treatment modalities used to manage periodontitis that have been designed to modulate the host response as it has been recognized that the host response, not the bacterial infection, is primarily responsible for the connective tissue destruction in chronic periodontitis. This study confirms the findings from studies in small animal models demonstrating increased activation of MAPKs in periodontal disease progression (Kirkwood et al. 2007b) , indicating that both increased MAPK expression and activation occurs with increased severity of periodontal disease in human tissues. Moreover, this is the first time that the levels of activation of MAPKs have been correlated with clinical parameters as well as BANA microbiological test results. These findings suggest that MAPK signalling plays a significant part of the ontogeny of inflammation in periodontal disease ultimately resulting in alveolar bone loss. 
